Moderna (MRNA) ticks higher after U.S. calls for a pause in &J (JNJ) vaccine after clotting cases

April 13, 2021 7:02 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Moderna (NASDAQ: MRNA) ticks higher after U.S. calls for a pause in &J (NYSE: JNJ) vaccine after clotting cases. Shares up 3.6%.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Trader Talk